VVOS Vivos Therapeutics: Operating Margin

Corporate emblem and logo of Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics (VVOS) maintains a strong position through its biomimetic, non-surgical treatment for apnea. The operating margin trend illustrates the effectiveness of this strategy, where -105.80 reflects the current value of the metric. The company is expanding its network of trained dentists, creating a unique treatment circuit. Insurance coverage for these services scales sales while optimizing distribution costs.

VVOS: Vivos Therapeutics, Inc. Operating Margin 07/04/2022 - 11/20/2026

Vivos Therapeutics - analytical breakdowns and key metrics (VVOS)

- share price and consensus valuation forecast:
Fundamental company analysis:VVOS, Vivos Therapeutics Inc.
Brand item of Vivos Therapeutics Inc

Vivos Therapeutics (VVOS) is scaling its presence in the apnea therapy segment, where growth in subscription checks directly impacts operating margins. This indicator reflects the portion of revenue remaining after covering all production costs before interest and taxes, allowing investors to assess the fundamental efficiency of the business model and the company's ability to generate internal cash flow.

Competitors of Vivos Therapeutics (VVOS)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|Return on Sales by Operating Profit STIM|SGHT (Sight Sciences Inc) - Operating Margin|OBIO: Operating Profit Rate|Operating Margin ANIK|Profitability of Operations inspiremd.com|Jin Medical International - Operating Sales Margin|Operating Margin Vivani Medical, Inc. VANI|XTNT: Operating Sales Margin|Operating Return on Sales NeuroOne Medical Technologies Corp.|MODD: Operating Margin|MYO - Profitability of Operations|Operating Profitability Envoy Medical Inc.|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)